Form 4 for TMDX TransMedics Group, Inc.
Accepted 2022-08-01 00:00:00 ET · period of report 2022-07-29 · accession 0000899243-22-027258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-01 | 2022-07-29+ | TMDX | Carey John F | VP of Ops | S - Sale+OE | $40.55 | -7,000 | 1,171 | -86% | -$283.8K |
| DM | 2022-08-01 | 2022-07-29+ | TMDX | Carey John F | VP of Ops | M - OptEx | $5.44 | +7,000 | 4,771 | New | +$38.1K |
| DM | 2022-08-01 | 2022-07-29+ | TMDX | Carey John F | VP of Ops | M - OptEx | $0.00 | -7,000 | 34.8K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-29 | S | D | 4,000 | $40.01 | 771 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.00 to $40.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F6) The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2022-08-01 | S | D | 400 | $40.02 | 3,371 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $39.60 to $40.39, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F6) The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2022-08-01 | S | D | 400 | $41.84 | 771 | D | — | — | (F5) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $41.78 to $41.95, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F6) The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 4 | Common | Common Stock | 2022-08-01 | S | D | 2,200 | $41.39 | 1,171 | D | — | — | (F4) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.78 to $41.76, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F6) The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 5 | Common | Common Stock | 2022-07-29 | M | A | 2,041 | $13.28 | 2,812 | D | — | — | (F6) The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 6 | Common | Common Stock | 2022-08-01 | M | A | 3,000 | $2.21 | 3,771 | D | — | — | (F6) The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 7 | Common | Common Stock | 2022-07-29 | M | A | 1,959 | $2.21 | 4,771 | D | — | — | (F6) The amount of securities directly owned by the Reporting Person includes 392 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-08-01 | M | D | 3,000 | $0.00 | 5,784 | D | $2.21 · — to 2027-06-22 | 3,000 Common Stock | (F8) The option is fully vested. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-07-29 | M | D | 1,959 | $0.00 | 8,784 | D | $2.21 · — to 2027-06-22 | 1,959 Common Stock | (F8) The option is fully vested. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-07-29 | M | D | 2,041 | $0.00 | 34,834 | D | $13.28 · — to 2032-02-22 | 2,041 Common Stock | (F7) The option vested and will continue to vest at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 22, 2022. As of the date of this report, the option remains subject to vesting with respect to 34,042 shares. |